Introduction
Prion diseases are lethal neurodegenerative disorders that affect humans and a variety of animal species. They include bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease in mule deer and elk, and Creutzfeldt-Jakob disease (CJD) in humans. The causative agent is termed prion (Prusiner, 1982) and was proposed to be identical with PrP Sc , a pathological conformer of the cellular protein PrP c encoded by the Prnp gene (Oesch et al., 1985; Basler et al., 1986) . PrP C is a glycosyl-phosphatidylinositol (GPI)-anchored glycopro-ent assays, we were not able to detect any PrP C -dependent modulation of SOD activity in heart, spleen, liver, brain as well as in synaptosome-enriched brain fractions. We conclude that a direct or indirect contribution of PrP C to SOD activity in these organs, at least under physiological conditions, appears to be unlikely.
Results and Discussion
The current study was undertaken to test whether PrP C modulates the total SOD activity in mouse tissues in vivo. Formally, PrP C may alter SOD activity, because (i) it possesses intrinsic dismutase activity, or (ii) because it modifies, directly or indirectly, the activity of the endogenous SOD1 enzyme -for example by altering copper metabolism. Finally (iii), PrP C may conceivably modify by unknown mechanisms, the activity and/or the tissue distribution of the mitochondrial SOD2 enzyme.
In order to prove or disprove each one of these hy- (Ho et al., 1998) with tga20 mice (Fischer et al., 1996) which overexpress PrP C ( Figure 1A ). For control experiments, we intercrossed transgenic mice overexpressing the human SOD1 gene, hSod1 (Epstein et al., 1987) , with tga20 mice. Genotypes were screened by PCR analysis ( Figure 1B -E) and confirmed by assessing the presence or absence of the proteins of interest by Western blot (SOD1, MnSOD, PrP C ), as well as functionally by analyzing SOD1 and SOD2 enzyme activity (Figure 2 ). Double and triple transgenic mice obtained in these crossings did not show obvious phenotypic alterations, except for mice homozygous for a disrupted SOD1 allele that exhibited reduced fertility, as described earlier (Ho et al., 1998) . All mice developed normally, had a normal life expectan- (A) Mice lacking SOD while expressing wild-type levels of PrP C (Sod -/-;Prnp +/+ ; Ho et al., 1998) were intercrossed with tga20 mice that transgenically express PrP C under the control of the Prnp promoter on a Prnp-deficient background leading to an overexpression of PrP C in all tissues (Fischer et al., 1996) while displaying wild-type levels of SOD1 (Sod1 +/+ ;Prnp o/o ;tga20 +/+ ). The F 1 -generation was intercrossed with each other to obtain the indicated genotypes in the F 2 -generation. (B) Mouse genotypes were identified by PCR analysis. The Prnp-status was revealed by a PCR using three primers within the same reaction (see Materials and Methods), resulting in a 362 bp band for the neo-cassette and a larger 546 bp band for Prnp + . (C) Specific primers were used for detecting the tga20 transgene resulting in a 740 bp band. (D) Presence of the Sod + wild-type allele was confirmed by a 182 bp band which is abolished in SOD1 -/--mice. The Sod -allele was demonstrated by an amplicon of 770 bp displaying the exon 4/neo cassette of the targeted Sod1-locus, whereas in (E) the human hSod1 transgene was revealed by a band of 573 bp. (B-E) Respective genotypes of mice are indicated and acy (> 350 days at the time of writing) and did not show histological abnormalities in brain, spleen, liver, kidney and heart (data not shown). Next, we evaluated SOD activity in brain, spleen, liver and heart of mice expressing varying amounts of PrP C . Using the xanthine/xanthine oxidase formazan based SOD assay, we were not able to detect any difference in total SOD activity between brain homogenates of Prnp o/o , wild-type, and tga20 mice which lack, express physiological amounts of, or overexpress PrP C , respectively ( Figure 3A, B) . These results are in line with those obtained by Waggoner and colleagues (2000) . In addition, we were not able to detect any SOD activity other than SOD2 in mice overexpressing PrP C but lacking SOD1 (Sod -/-;tga20 +/-or Sod -/-;tga20 +/+ ; Figure 3A -D). This indicates that PrP C , even when expressed at supraphysiological levels, does not exhibit any intrinsic SOD activity in vivo. Similar results to those in brain ( Figure 3A , B) were obtained in heart ( Figure 3C , D), spleen ( Figure 3E ) and liver (data not shown), consistently and regardless of whether samples were analyzed in kinetic ( Figure 3A , B, E) or endpoint mode ( Figure 3C, D) , in which decrease in the reaction speed or inhibition of formazan production are plotted, respectively.
Inhibition of SOD1 activity by KCN revealed no detectable levels of MnSOD in brain ( Figure 3B ), liver, and spleen of any of the mice investigated (data not shown) and confirmed the specificity of the assay. In contrast, MnSOD was readily detectable in mitochondria-rich heart homogenates and, similar to SOD1, appeared to be independent of PrP C -expression levels (Fig 3C, D) . Multiple independent experiments and use of alternative homogenization buffers and procedures (0.5% NP-40 and 0.5% DOC or sonication followed by ultracentrifugation at 78 000 g for 30 min) as described earlier (Ewing and Janero, 1995) produced the same results (data not shown). An additional, independent SOD assay based on auto-oxidation (Nebot et al., 1993) yielded identical results ( Figure 3F ). Repeated measurements confirmed that the latter assay was robust and highly reproducible with control material and all experimental samples (data not shown).
The highest concentration of PrP C is found in synaptosome-enriched subcellular fractions, leading to speculations that PrP C may serve as a copper buffer in the synaptic cleft (Brown et al., 1997a; Kretzschmar et al., 2000) . We therefore assayed the SOD activity of synaptosomeenriched brain fractions of mice of all the genotypes described above. In order to confirm the presence of SOD1 and of PrP C in crude synaptosomal brain fractions, aliquots of each sample were subjected to Western blot analysis in addition to SOD activity assays ( Figure 4A ). Again, and in flagrant contrast to other reports (Brown and Besinger, 1998; Brown et al., 1999; Milhavet et al., 2000; Wong et al., 2000; Brown et al., 2002; Klamt et al., 2001; Milhavet and Lehmann, 2002) we did not find any contribution of PrP C to the overall SOD activity, nor did we detect any intrinsic SOD activity of PrP C in crude synaptosomal brain fractions ( Figure 4B ).
Our results indicate that modulation of PrP C levels does not influence the SOD activity in a series of tissues, including brain. The data presented here were collected from organs of genetically defined mouse models lacking or expressing various levels of PrP C in the presence or absence of endogenous SOD1, whereas most data deposing in favor an SOD activity of PrP C were recorded with recombinant proteins. In addition, the xanthine-xanthine oxidase based assay (Okado-Matsumoto and Fridovich, 2001 ) used in this study may be more sensitive and less error-prone than the NBT-method mainly used in previous studies (Brown et al., 1997b Brown and Besinger, 1998; Milhavet et al., 2000; Wong et al., 2000) . The NBT assay was shown to potentially interfere with xanthine oxidase (Ukeda et al., 1997) and resulted in a No SOD Activity of PrP C in vivo 1281 poor reproducibility in our hands. While PrP C or peptides thereof might exhibit a SOD1-mimetic function under rather artificial settings in vitro, our results indicate that in vivo a contribution of PrP C to the SOD activity or a direct SOD-like function of PrP C , at least under physiological conditions, appears to be unlikely. Certainly, it cannot be excluded that PrP C merely under conditions of stress exhibits a SOD-like function and, consequently, abrogation of PrP C , e.g. in the course of prion disease, where PrP C is converted into PrP Sc , might be causally linked to increased free radical formation and thus accelerate neurodegeneration. This scenario, however, appears to be less likely, since SOD1-activity levels and SOD1 protein expression are not decreased in brains of scrapie-infect- 6) . No significant SOD-activity was measurable in mice lacking SOD1 (lanes 1 -2), even when PrP C was overexpressed (lane 2). As positive control mice overexpressing the human SOD1 (lane 3) were used yielding high SOD levels. (B) KCN-inhibition of same samples as in (A) resulting in a complete inhibition of SOD1, thus displaying MnSOD activity. While the MnSOD enzyme was present in brain extracts (see Figure 2B ), its activity even on a SOD1 -/--background (lanes 1 -2) could not be detected in brain, spleen (not shown) and liver (not shown) samples. Merely a residual SOD1 activity in transgenic hSod1 mice was detectable, since 15 mM KCN were not sufficient to completely abolish human SOD1 overexpression. Values are indicated as v max in mOD/min in the linear range of the assay. (C) and (D) indicate percent inhibition of WST-Formazan reduction in a xanthine-xanthine oxidase based SOD-assay with an endpoint measurement at 450 nm in heart homogenates yielding similar results as in (A). In mitochondria-rich heart fractions, MnSOD is readily detectable upon adding 15 mM KCN at similar levels independent of the level of PrP C expression. (E) Kinetic measurement of WST-formazan reduction in a xanthine-xanthine oxidase based SOD-assay in spleen homogenates also displays no contribution of PrP C to the SOD-activity (lanes 4 and 5) or an intrinsic SOD-like activity in the absence of SOD1 (lane 2 vs. 1). Again, mice overexpressing the human SOD1 (lane 3) served as positive control. (F) Similarly as in the formazan based assay (see 3A), no SOD-like activity of PrP C in brain homogenates was detectable when a SOD-assay was used that is based on auto-oxidation. ed hamsters (Choi et al., 1998) and mice . In addition, we were also not able to detect any alteration of SOD1 protein levels in terminally scrapie-sick mouse brains (G.H., F.L.H. and A.A., unpublished observations).
The negative results reported here certainly do not negate a role for reactive oxygen species in prion pathogenesis. Oxidative stress may play a role in a variety of neurodegenerative diseases (Perry et al., 2002) . It will therefore be interesting to test whether absence or overexpression of SOD1 alters susceptibility of mice to prion infection, and to assess the capability of mice lacking SOD1 to cope with oxidative stress in the presence or absence of PrP C .
Materials and Methods

Generation and Genotyping of Transgenic Mice
Prnp o/o (Büeler et al., 1992) and tga20 mice (Fischer et al., 1996) were intercrossed with Sod1 -/-mice lacking the endogenous SOD1 protein (Ho et al., 1998;  Figure 1A ), or with transgenic hSod1 mice (Epstein et al., 1987) Figure 1B-D) . The following primers were used: Detection of the Prnp + and Prnp o alleles using 3 primers within the same PCR reaction as described (Fischer et al., 1996) : (5' ATT CGC AGC GCA TCG CCT TCT ATC GCC 3'), (5' GTA CCC ATA ATC AGT GGA ACA AGC CCA GC 3'), (5' CCC TCC CCC AGC CTA GAC CAC GA 3'). Detection of the transgenic tga20 + allele: (5' CAA CCG AGC TGA AGC ATT CTG CCT 3'), (5' CCT GGG ACT CCT TCT GGT ACC GGG TGA CGC 3'). Detection of the transgenic hSod1 allele: (5' TGG GTA TTG TTG GGA GGA GG 3'), (5' TCT GTT CCA CTG AAG CTG TT 3'). Detection of the Sod + allele by amplifying exon 5 of the murine Sod1-locus which is removed in the Sod1 -/-mice by targeted disruption (Ho et al., 1998) : (5' CTT GAT CAT TCA AAC CTA AAT GTT CTT 3'), (5' CAG TTG AGT CTG AGA CTT CAG ACC ACA 3'). Detection of the Sod -allele by amplifying the exon 4/neo cassette in Sod1 -/-mice (Ho et al., 1998) : (5' GAA CAT CGT GTG ATC TCA CTC TCA GGA GAG 3'), (5' AAA AGC GCC TCC CCT ACC CGG TAG AAT TGA 3').
Non-Denaturing Gel-Electrophoresis and SOD Zymography
To confirm functionally the presence or absence of endogenous SOD and/or transgenic human Cu 2 + /Zn 2 + -superoxide dismutase (hSOD1) activity, erythrocytes were subjected to non-denaturing gel-electrophoresis as described (Beauchamp and Fridovich, 1971) . Erythrocytes were lysed, loaded on a non-denaturing gel, and electrophoresed. Gels were stained with 1 mg/ml nitro-blue tetrazolium (NBT) for 20 min and thereafter soaked in 0.036 M potassium phosphate buffer (all reagents were purchased from Sigma Inc., Buchs, Switzerland, unless otherwise specified), pH 7.8, containing 10 µg/ml riboflavin and 3 µl/ml TEMED. Generation of superoxide radicals was induced by subjecting the gels to ultraviolet light resulting in reduction of NBT. Areas with SOD activity remained unstained due to superoxide dismutation (Figure 2A ).
Histological Analysis
Mice were deeply anaesthetized, and brain, heart, liver and spleen were removed and fixed in 4% paraformaldehyde in PBS. After embedding the organs in paraffin, tissue was processed according to standard procedures and routinely stained with hematoxylin and eosin (H&E; data not shown).
Preparation of Synaptosome-Enriched Brain Fractions
Synaptosome-enriched brain fractions were prepared according to a protocol provided by Dr. Lloyd Vaughan (Veterinary Pathology, University of Zürich, Zürich, Switzerland). Mice were deeply anaesthetized and brains were removed. Next, brain tissue was cut into small pieces with a razor blade and homogenized by a teflon/glass homogenizer (12 strokes) in 10 volumes of ice-cold buffered sucrose (320 mM sucrose, 4 mM HEPES, pH 7.4) supplemented with a protease inhibitor cocktail (1 tablet per 10 ml No SOD Activity of PrP C in vivo 1283 (A) were subjected to WST-formazan reduction in a xanthine-xanthine oxidase based SOD-assay with an endpoint measurement at 450 nm. Percent inhibition of WST-formazan reduction of crude synaptosomes is illustrated. Again, no contribution of PrP C to the overall SOD activity (lanes 5 -7), nor a SODlike activity of PrP C , even when overexpressed, was detectable in the absence of endogenous SOD1 (lanes 1 -2). Synaptosomal fractions of mice overexpressing human SOD1 served as positive controls (lanes 2 -3). Two independent experiments were performed of which one representative is displayed. Each experiment was performed in triplicate and mean value ± standard deviation is depicted.
homogenate; Roche, Rotkreuz, Switzerland). Thereafter, homogenates were centrifuged for 10 min at 1100 g at 4°C. Supernatant was transferred to a new tube and centrifuged for 15 min at 9200 g at 4°C for a second time. The pellet was resuspended in 10 ml ice-cold buffered sucrose and centrifuged once more for 15 min at 10 500 g at 4°C. The resulting pellet consisting of crude synaptosomes was then used for Western blot analysis or for SOD assays.
SOD Assays
Mice were deeply anaesthetized and perfused with ice-cold PBS (pH 7.4) in order to remove blood cells. Brain, liver, spleen and heart were excised, snap-frozen in liquid nitrogen, and stored at -80°C until further use. Samples were weighed and thawed in ice-cold 50 mM phosphate buffer (pH 7.4) containing a proteinase inhibitor cocktail (1 tablet per 10 ml homogenate; Roche). Samples were homogenized with a Polytron tissue grinder, and crude homogenates were centrifuged at 15 000 g for 30 min at 4°C. Supernatant was then analyzed by a standard BCA assay (Pierce, Rockford, USA) to determine protein concentration. All samples were then adjusted to the same concentration.
Three different SOD assays were used to analyze SOD and SOD-mimetic activity: First, a xanthine/xanthine-oxidase based assay (Dojindo Molecular Technologies) was performed according to the manufacturer's instruction. This assay utilizes the sodium salt of 4-[3-(4iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate, a water-soluble tetrazolium (WST), as a detector of superoxide radical generation (Peskin and Winterbourn, 2000) . The assay was standardized by measuring SOD activity of bovine erythrocytes (data not shown). Selective inhibition of SOD1 activity in Sod1 +/+ -Prnp +/+ mice was achieved by adding 15 mM potassium cyanide (KCN) for 30 min on ice, thus allowing to assess the activity of the manganese SOD (MnSOD or SOD2). Lower doses of KCN, in contrast to other reports (Okado-Matsumoto and Fridovich, 2001), did not result in complete inhibition of SOD1 in our experimental series. Two µg of total protein were analyzed per reaction; experiments were run in triplicates and analyzed in a 96-well plate reader (SpectraMax, Molecular Devices Corporation, Sunnyvale, USA). Upon application of the enzyme solution, the linear increase of absorption at 450 nm was monitored constantly over 30 min in kinetic or endpoint mode at 37°C. Inhibition of formazan production was plotted against corresponding blank controls.
The second SOD assay is based on the SOD-mediated increase in the rate of autoxidation of 5,6,6a,11b-tetrahydro-3,9,10-trihydroxybenzo[c]fluorene in aqueous alkaline solution, which generates a chromophore with a wavelength of maximal absorbance at 525 nm (Nebot et al., 1993) . The assay was performed according to the instructions of the manufacturer (Calbiochem, San Diego, USA). Tissue extracts were prepared as described above, and 250 µl homogenate with a concentration of 5 µg/µl of total protein were subjected to ethanol/chloroform (67.5/32.5 v/v) extraction. Thereafter, 40 µl of supernatant were incubated with the assay reagents as described according to the manufacturer's instructions. Absorption at 525 nm and 37°C was monitored for 5 min. Increase of absorption per time of different samples in the linear range of the assay was plotted. All kinetic and endpoint data were processed automatically by the SOFTMax Pro software (SpectraMax).
Thirdly, we attempted to establish an NBT-based assay using the non-enzymatic superoxide generator phenazine methosulfate in combination with NADH (Ewing and Janero, 1995) . Samples were prepared as described above. Additionally, sonication of the extract and/or treatment with 0.5% DOC and 0.5% NP-40 followed by ultracentrifugation (78 000 g, 30 min) was performed. However, we experienced poor reproducibility and variability in repeated measurements of the same probes; therefore this assay was excluded from further analyses.
Western Blots
Aliquots of the same tissue homogenates as used for SOD assays were run on SDS-PAGE gels (5% stacking and 16% resolving) and transferred on nitrocellulose (Schleicher & Schuell, Dassel, Germany) by wet blotting. Membranes were blocked with 5% Top-Block (Juro, Luzern, Switzerland) in Tris-buffered salineTween (TBS-T) at room temperature (RT) for 1 hour and, thereafter, incubated for one hour at RT with the primary antibody diluted in 1% Top-Block in TBS-T. As primary antibody we used an anti-PrP antibody (ICSM18; kind gift of Dr. S. Hawke, London, UK; dilution 1:30 000), an anti-SOD1 antibody (Calbiochem; dilution 1:1 000: approximately 16 kDa), an anti-SOD2 antibody (Stressgen, Victoria, Canada; dilution 1:5 000; approx. 25 KDa) or an anti-β-actin antibody (Jackson, USA; dilution 1: 5 000). Membranes were washed three times for 15 min in TBS-T, and incubated for further 45 minutes with a horseradish peroxidase (HRP)-labeled secondary antibody diluted in 1% Top-Block in TBS-T. As secondary antibody we used rabbit-anti-mouse IgG 1 -HRP (Zymed, South San Francisco, USA, dilution 1:10 000) for detecting anti-PrP and anti-β-actin antibodies or goat-antisheep IgG-HRP for detecting anti-SOD1 and anti-SOD2 antibodies (Jackson; dilution 1:10 000). Membranes were washed three times for 15 min in TBS-T and developed using enhanced chemiluminescence (ECL, Pierce) detection reagents.
